Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria

Authors: Kristoffersson, A.N., Rognås, V., Brill, M.J.E., Dishon-Benattar, Y., Durante-Mangoni, E., Daitch, V., Skiada, A., Lellouche, J., Nutman, A., Kotsaki, A., Andini, R., Eliakim-Raz, N., Bitterman, R., Antoniadou, A., Karlsson, M.O., Theuretzbacher, U., Leibovici, L., Daikos, G.L., Mouton, J.W., Carmeli, Y., Paul, M., Friberg, L.E.

Source: In Clinical Microbiology and Infection December 2020 26(12):1644-1650

Antibiotic innovation for future public health needs

Authors: Theuretzbacher, U.

Source: In Clinical Microbiology and Infection October 2017 23(10):713-717

Closing the evidence gap in infectious disease: point-of-care randomization and informed consent

Authors: Huttner, A., Leibovici, L., Theuretzbacher, U., Huttner, B., Paul, M.

Source: In Clinical Microbiology and Infection February 2017 23(2):73-77

Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective

Authors: Muller, A.E., Theuretzbacher, U., Mouton, J.W.

Source: In Clinical Microbiology and Infection October 2015 21(10):881-885

The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections

Authors: Tängdén, T., Ramos Martín, V., Felton, T. W., Nielsen, E. I., Marchand, S., Brüggemann, R. J., Bulitta, J. B., Bassetti, M., Theuretzbacher, U., Tsuji, B. T.

Source: INTENSIVE CARE MEDICINE. 43(7):1021-1032

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN384515639&indx=1&recIds=ETOCRN384515639

Reviving old antibiotics

Authors: Theuretzbacher, U., Van Bambeke, F. o., Cantón, R., Giske, C. G., Mouton, J. W., Nation, R. L., Paul, M., Turnidge, J. D., Kahlmeter, G.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 70(8):2177-2181

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN371414512&indx=1&recIds=ETOCRN371414512

Antibiotic research and development: business as usual?

Authors: Harbarth, S., Theuretzbacher, U., Hackett, J.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 70(6):1604-1607

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN371414275&indx=1&recIds=ETOCRN371414275

Combination therapy for carbapenem-resistant Gram-negative bacteria

Authors: Paul, M., Carmeli, Y., Durante-Mangoni, E., Mouton, J. W., Tacconelli, E., Theuretzbacher, U., Mussini, C., Leibovici, L.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 69(9):2305-2309

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN357892532&indx=1&recIds=ETOCRN357892532

Product information for parenteral colistin varies substantially across Europe

Authors: Theuretzbacher, U.

Source: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 69(7):1987-1992

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN354789496&indx=1&recIds=ETOCRN354789496

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Authors: Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., Drusano, G., Frey, O. R., Theuretzbacher, U., Kuti, J. L.

Source: LANCET INFECTIOUS DISEASES. 14(6):498-509

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN352757769&indx=1&recIds=ETOCRN352757769

Pharmacokinetic and Pharmacodynamic Issues for Antimicrobial Therapy in Patients With Cancer

Authors: Theuretzbacher, U.

Source: CLINICAL INFECTIOUS DISEASES -CHICAGO-. 54(12):1785-1792

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN353092079&indx=1&recIds=ETOCRN353092079

Accelerating resistance, inadequate antibacterial drug pipelines and international responses

Authors: Theuretzbacher, U.

Source: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 39(4):295-299

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN308758990&indx=1&recIds=ETOCRN308758990

The Effect of Critical Illness on Drug Distribution

Authors: Gonzalez/snm, D., Conrado, D.J., Theuretzbacher, U., Derendorf, H.

Source: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 12(12):2030-2036

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN303610715&indx=1&recIds=ETOCRN303610715

Update on antibacterial and antifungal drugs - can we master the resistance crisis?
Anti-infectives/ New technologies

Authors: Theuretzbacher, U., Mouton, J. W.

Source: CURRENT OPINION IN PHARMACOLOGY. 11(5):429-432

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN298258352&indx=1&recIds=ETOCRN298258352

Resistance drives antibacterial drug development
Anti-infectives/ New technologies

Authors: Theuretzbacher, U.

Source: CURRENT OPINION IN PHARMACOLOGY. 11(5):433-438

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN298258364&indx=1&recIds=ETOCRN298258364

Protein Binding: Do We Ever Learn?

Authors: Zeitlinger, M.A., Derendorf, H., Mouton, J.W., Cars, O., Craig, W.A., Andes, D., Theuretzbacher, U.

Source: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY -JOURNAL-. 55(7):3067-3074

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN295162294&indx=1&recIds=ETOCRN295162294

Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

Authors: Mouton, J. W., Ambrose, P. G., Canton, R., Drusano, G. L., Harbarth, S., MacGowan, A., Theuretzbacher, U., Turnidge, J.

Source: DRUG RESISTANCE UPDATES. 14(2):107-117

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN290909556&indx=1&recIds=ETOCRN290909556

Pharmacokinetic/Pharmacodynamic Profile of Posaconazole

Authors: Li, Y., Theuretzbacher, U., Clancy, C.J., Nguyen, M.H., Derendorf, H.

Source: CLINICAL PHARMACOKINETICS. 49(6):379-396

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN273533629&indx=1&recIds=ETOCRN273533629

Antibiotics: derivative drugs, novel compounds and the need for effective resistance strategies

Authors: Theuretzbacher, U.

Source: FUTURE MICROBIOLOGY. 4(10):1243-1248

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN262628590&indx=1&recIds=ETOCRN262628590

Future antibiotics scenarios: is the tide starting to turn?

Authors: Theuretzbacher, U.

Source: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 34(1):15-20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN250994540&indx=1&recIds=ETOCRN250994540